Moderna Inc header image

Moderna Inc

MRNA

Equity

ISIN null / Valor 44811242

NASDAQ (2026-11-10)
USD 271.06+5.83%

Moderna Inc
UMushroom community rating:

star star star star star
3.56 18 votes No rating yet
NegativeNeutralPositive

About company

Moderna, Inc. is a publicly traded biotechnology company (NASDAQ: MRNA) headquartered in Cambridge, Massachusetts, that develops and commercializes medicines and vaccines based on messenger RNA (mRNA) technology. Founded in 2010, the firm built an mRNA platform that pairs synthetic mRNA constructs with lipid nanoparticle delivery to produce target proteins in patients, and its highest-profile product is the COVID-19 vaccine Spikevax, which has driven significant commercial revenue and government contracts. Beyond COVID-19, Moderna maintains a broad pipeline across infectious disease vaccines, oncology (including personalized cancer vaccine programs), rare and cardiometabolic diseases, and other therapeutic areas, and it has invested in clinical development, scale-up of manufacturing capacity, and partnerships with public and private research organizations to advance and commercialize its candidates.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

996%1Y
287%3Y
13.6%5Y

Performance

129%1Y
91.7%3Y
81.6%5Y

Volatility

Market cap

108843 M

Market cap (USD)

Daily traded volume (Shares)

12,357,426

Daily traded volume (Shares)

1 day high/low

40.5 / 38.89

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.56

18 votes
Performance:
starstarstarstarstar
3.52
Innovation:
starstarstarstarstar
4.19
Society:
starstarstarstarstar
3.83
Nature:
starstarstarstarstar
3.36
Jakub Furmanek
UK, 08 Nov 2026
star star star star star
Risky stock
Dora Chen
UK, 06 Nov 2026
star star star star star
-
Lucas Dannhuaser
UK, 06 Nov 2026
star star star star star
good

EQUITIES OF THE SAME SECTOR

Amadeus IT Group S.A
Amadeus IT Group S.A Amadeus IT Group S.A Valor: 11249889
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%EUR 60.58
Masterflex SE
Masterflex SE Masterflex SE Valor: 1091276
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.69%EUR 14.50
Gubra A/S
Gubra A/S Gubra A/S Valor: 125706804
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.71%DKK 310.60
Hyrican Informationssysteme AG
Hyrican Informationssysteme AG Hyrican Informationssysteme AG Valor: 1094755
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.96%EUR 5.20
plenum AG
plenum AG plenum AG Valor: 29187745
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.00%EUR 1.90
CPU Softwarehouse AG
CPU Softwarehouse AG CPU Softwarehouse AG Valor: 4924656
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.02%EUR 0.45
Springer Nature AG & Co. KGaA
Springer Nature AG & Co. KGaA Springer Nature AG & Co. KGaA Valor: 41578404
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.40%EUR 21.80
Samsung Electronics Co., Ltd. Sponsored GDR
Samsung Electronics Co., Ltd. Sponsored GDR Samsung Electronics Co., Ltd. Sponsored GDR Valor: 381611
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.90%GBP 2,768.04
Compal Electronics, Inc. Sponsored GDR RegS
Compal Electronics, Inc. Sponsored GDR RegS Compal Electronics, Inc. Sponsored GDR RegS Valor: 1015809
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.31%GBP 2.31
74Software
74Software 74Software Valor: 13107851
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.59%EUR 34.30